Coastview Capital

Coastview Capital is a venture capital firm that is located in Southern California and is focused solely on life science investments. The firm seeks biotechnology companies that are most likely to improve medicine through their potential to create new therapeutics or which have the promise of transforming medicine by drastically improving the drug discovery process. Coastview considers direct equity investments across all stages of development. The firm typically invests $1-5 million initially, and up to a total of $10 million over the life of the company. Coastview considers investments in all geographical areas, depending on the investment criteria being met and the involvement of other key investors. Coastview's preferred regions for investments are Southern California, Boston, the San Francisco Bay area, and the greater Washington D.C. area. Coastview currently has $72 million under management. Founder, Gordon Binder, was CEO of Amgen from 1988-2000.